scholarly article | Q13442814 |
P356 | DOI | 10.1191/096120399678847597 |
P698 | PubMed publication ID | 10342715 |
P50 | author | Yehuda Shoenfeld | Q1515807 |
Yair Levy | Q73255332 | ||
Boris Gilburd | Q73268544 | ||
Jacob George | Q73291725 | ||
Pnina Langevitz | Q73421809 | ||
P2093 | author name string | D Harats | |
P433 | issue | 3 | |
P921 | main subject | systemic lupus erythematosus | Q1485 |
P304 | page(s) | 220-226 | |
P577 | publication date | 1999-01-01 | |
P1433 | published in | Lupus | Q6704846 |
P1476 | title | Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis | |
P478 | volume | 8 |
Q34354736 | Accelerated atheroma, antiphospholipid antibodies, and the antiphospholipid syndrome |
Q34504768 | Antibodies and vascular involvement in inflammatory joint disease: clinical relevance |
Q33976585 | Autoimmunity in atherosclerosis. The role of autoantigens |
Q37425906 | Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors |
Q73289480 | Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain |
Q90324844 | Dysregulated serum lipid profile and its correlation to disease activity in young female adults diagnosed with systemic lupus erythematosus: a cross-sectional study |
Q35549285 | Inflammation-mediated rheumatic diseases and atherosclerosis |
Q42675484 | Lipidomics profiling reveals the role of glycerophospholipid metabolism in psoriasis |
Q46889699 | Lysophosphatidylcholine as a ligand for immunoregulation |
Q35061594 | Lysophosphatidylcholine triggers TLR2- and TLR4-mediated signaling pathways but counteracts LPS-induced NO synthesis in peritoneal macrophages by inhibiting NF-κB translocation and MAPK/ERK phosphorylation |
Q42211562 | Lysophosphatidylcholine-induced surface redistribution regulates signaling of the murine G protein-coupled receptor G2A. |
Q39550704 | Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Effect on carotid intima-media thickness |
Q34757801 | Methotrexate in atherogenesis and cholesterol metabolism |
Q28214132 | Mixed connective tissue disease associated with antineutrophil cytoplasmic antibodies against proteinase-3 and systemic atherosclerosis: a case report |
Q37276377 | Pathogenesis of atherosclerosis: A multifactorial process. |
Q36644837 | Risk factors in cardiovascular disease in systemic lupus erythematosus |
Q49392673 | Stearoyl Lysophosphatidylcholine Inhibits Endotoxin-Induced Caspase-11 Activation |
Q79934477 | Subclinical impairment of arterial mechanics in systemic lupus erythematosus identified by arterial waveform analysis |
Q35169351 | The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus |
Q33575750 | The lupus susceptibility locus Sle3 is not sufficient to accelerate atherosclerosis in lupus-susceptible low density lipoprotein receptor-deficient mice. |
Search more.